newsfilter
← Latest News
GlobeNewswire·

Acer Therapeutics Compliant with All Nasdaq Listing Criteria

NEWTON, Mass., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (NASDAQ:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and